Canadian application, no grantCanada
Methods of use of gemifloxacin compounds against fluoroquinolone resistant streptococcus pneumoniae bacteria
CA 2283352 A1 · Owner: Mandell, Lionel A. · Inventors: Low, Donald E.; Davidson, Ross J.; Bast, Darren
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates, in part, to newly identified methods of using quinolone, antibiotics, particularly a gemifloxacin compound against certain pathogenic bacteria.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 23, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 23, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 23, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 23, 1999
GrantedNo grant recorded
Term endedSeptember 23, 2019
Patent numberCA 2283352 A1
Classification (IPC)A61K31/43 +1 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.